Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2001 Jul 1;33 Suppl 1:S38-46.

Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients.

Author information

  • 1Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. jkp@bugs.uah.ualberta.ca

Abstract

The Epstein-Barr virus (EBV) has a pivotal pathophysiologic role in the development of most lymphoproliferative disorders that occur after solid-organ transplantation. The term "EBV-associated posttransplant lymphoproliferative disorder" (PTLD) includes all clinical syndromes of EBV-associated lymphoproliferation, ranging from uncomplicated posttransplant infectious mononucleosis to true malignancies that contain clonal chromosomal abnormalities. PTLDs are historically associated with a high mortality rate in patients who have a monoclonal form of the disorder. Recently described approaches to pathology, diagnosis, treatment, and preventive strategies of PTLD, however, have the potential to improve outcome.

[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk